BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36438484)

  • 1. Single-cell transcriptomics of peripheral blood reveals anti-tumor systemic immunity induced by oncolytic virotherapy.
    Wu Q; Hu X; Zhang X; Kong D; Yang Z; Li G; Gu Z; Zhang Q; Wan D; Cheng S; Liu B; Zhang K; Zhang W
    Theranostics; 2022; 12(17):7371-7389. PubMed ID: 36438484
    [No Abstract]   [Full Text] [Related]  

  • 2. SIRPα antibody combined with oncolytic virus OH2 protects against tumours by activating innate immunity and reprogramming the tumour immune microenvironment.
    Kong D; Yang Z; Li G; Wu Q; Gu Z; Wan D; Zhang Q; Zhang X; Cheng S; Liu B; Zhang K; Zhang W
    BMC Med; 2022 Oct; 20(1):376. PubMed ID: 36310169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OX40L-Armed Oncolytic Virus Boosts T-cell Response and Remodels Tumor Microenvironment for Pancreatic Cancer Treatment.
    Liu S; Li F; Ma Q; Du M; Wang H; Zhu Y; Deng L; Gao W; Wang C; Liu Y; Zhao Z; Liu H; Wang R; Tian Y; Hu M; Wan Y; Lu W; Zhang M; Zhao M; Cao Y; Zhang H; Wang W; Wang H; Wang Y
    Theranostics; 2023; 13(12):4016-4029. PubMed ID: 37554264
    [No Abstract]   [Full Text] [Related]  

  • 4. Comprehensive characterization of tumor immune landscape following oncolytic virotherapy by single-cell RNA sequencing.
    Ravirala D; Pei G; Zhao Z; Zhang X
    Cancer Immunol Immunother; 2022 Jun; 71(6):1479-1495. PubMed ID: 34716463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating mechanisms of antitumor immunity mediated by live oncolytic vaccinia and heat-inactivated vaccinia.
    Wang W; Liu S; Dai P; Yang N; Wang Y; Giese RA; Merghoub T; Wolchok J; Deng L
    J Immunother Cancer; 2021 Sep; 9(9):. PubMed ID: 34593618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An oncolytic HSV-1 armed with Visfatin enhances antitumor effects by remodeling tumor microenvironment against murine pancreatic cancer.
    Zhao J; Wang H; Chen J; Wang C; Gong N; Zhou F; Li X; Cao Y; Zhang H; Wang W; Zheng H; Zhang C
    Biochem Biophys Res Commun; 2024 Jul; 718():149931. PubMed ID: 38723415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spatial and single-cell analysis reveals remodeled immune microenvironment induced by synthetic oncolytic adenovirus treatment.
    Liu G; Hu Q; Peng S; Ning H; Mai J; Chen X; Tao M; Liu Q; Huang H; Jiang Y; Ding Y; Zhang X; Gu J; Xie Z
    Cancer Lett; 2024 Jan; 581():216485. PubMed ID: 38008394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade.
    Chon HJ; Lee WS; Yang H; Kong SJ; Lee NK; Moon ES; Choi J; Han EC; Kim JH; Ahn JB; Kim JH; Kim C
    Clin Cancer Res; 2019 Mar; 25(5):1612-1623. PubMed ID: 30538109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidirectional Strategies for Targeted Delivery of Oncolytic Viruses by Tumor Infiltrating Immune Cells.
    Osali A; Zhiani M; Ghaebi M; Meymanat M; Esmaeilzadeh A
    Pharmacol Res; 2020 Nov; 161():105094. PubMed ID: 32795509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel oncolytic virus induces a regional cytokine storm and safely eliminates malignant ascites of colon cancer.
    Dong S; Liu B; Hu S; Guo F; Zhong Y; Cai Q; Zhang S; Qian Y; Wang J; Zhou F
    Cancer Med; 2022 Nov; 11(22):4297-4309. PubMed ID: 35510373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intratumoral OH2, an oncolytic herpes simplex virus 2, in patients with advanced solid tumors: a multicenter, phase I/II clinical trial.
    Zhang B; Huang J; Tang J; Hu S; Luo S; Luo Z; Zhou F; Tan S; Ying J; Chang Q; Zhang R; Geng C; Wu D; Gu X; Liu B
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33837053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced antitumor efficacy of a novel oncolytic vaccinia virus encoding a fully monoclonal antibody against T-cell immunoglobulin and ITIM domain (TIGIT).
    Zuo S; Wei M; He B; Chen A; Wang S; Kong L; Zhang Y; Meng G; Xu T; Wu J; Yang F; Zhang H; Wang S; Guo C; Wu J; Dong J; Wei J
    EBioMedicine; 2021 Feb; 64():103240. PubMed ID: 33581644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific targeting of glioblastoma with an oncolytic virus expressing a cetuximab-CCL5 fusion protein via innate and adaptive immunity.
    Tian L; Xu B; Chen Y; Li Z; Wang J; Zhang J; Ma R; Cao S; Hu W; Chiocca EA; Kaur B; Caligiuri MA; Yu J
    Nat Cancer; 2022 Nov; 3(11):1318-1335. PubMed ID: 36357700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural Killer Cells Recruitment in Oncolytic Virotherapy: A Mathematical Model.
    Senekal NS; Mahasa KJ; Eladdadi A; de Pillis L; Ouifki R
    Bull Math Biol; 2021 May; 83(7):75. PubMed ID: 34008149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal timing of PD-1 blockade in combination with oncolytic virus therapy.
    Nguyen HM; Bommareddy PK; Silk AW; Saha D
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):971-980. PubMed ID: 34033895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral expression of interleukin 23 variants using oncolytic vaccinia virus elicit potent antitumor effects on multiple tumor models via tumor microenvironment modulation.
    Chen L; Chen H; Ye J; Ge Y; Wang H; Dai E; Ren J; Liu W; Ma C; Ju S; Guo ZS; Liu Z; Bartlett DL
    Theranostics; 2021; 11(14):6668-6681. PubMed ID: 34093846
    [No Abstract]   [Full Text] [Related]  

  • 17. Co-delivery of novel bispecific and trispecific engagers by an amplicon vector augments the therapeutic effect of an HSV-based oncolytic virotherapy.
    Ravirala D; Mistretta B; Gunaratne PH; Pei G; Zhao Z; Zhang X
    J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34230110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Counteracting Immunosuppression in the Tumor Microenvironment by Oncolytic Newcastle Disease Virus and Cellular Immunotherapy.
    Schirrmacher V; van Gool S; Stuecker W
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reshaping the Immune Microenvironment by Oncolytic Herpes Simplex Virus in Murine Pancreatic Ductal Adenocarcinoma.
    Zhang L; Wang W; Wang R; Zhang N; Shang H; Bi Y; Chen D; Zhang C; Li L; Yin J; Zhang H; Cao Y
    Mol Ther; 2021 Feb; 29(2):744-761. PubMed ID: 33130310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dendritic Cells in Oncolytic Virus-Based Anti-Cancer Therapy.
    Kim Y; Clements DR; Sterea AM; Jang HW; Gujar SA; Lee PW
    Viruses; 2015 Dec; 7(12):6506-25. PubMed ID: 26690204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.